|Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010|
MA Bachhuber, B Saloner, CO Cunningham, CL Barry
JAMA internal medicine 174 (10), 1668-1673, 2014
|Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996–2013|
MA Bachhuber, S Hennessy, CO Cunningham, JL Starrels
American journal of public health 106 (4), 686-688, 2016
|High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic|
BL Norton, J Fleming, MA Bachhuber, M Steinman, J DeLuca, ...
International journal of drug policy 47, 196-201, 2017
|Primary care physicians’ perspectives on the prescription opioid epidemic|
A Kennedy-Hendricks, SH Busch, EE McGinty, MA Bachhuber, ...
Drug and alcohol dependence 165, 61-70, 2016
|The emerging public discourse on state legalization of marijuana for recreational use in the US: Analysis of news media coverage, 2010–2014|
EE McGinty, H Samples, SN Bandara, B Saloner, MA Bachhuber, ...
Preventive medicine 90, 114-120, 2016
|Insurance coverage and treatment use under the Affordable Care Act among adults with mental and substance use disorders|
B Saloner, S Bandara, M Bachhuber, CL Barry
Psychiatric services 68 (6), 542-548, 2017
|Messaging to increase public support for naloxone distribution policies in the United States: results from a randomized survey experiment|
MA Bachhuber, EE McGinty, A Kennedy-Hendricks, J Niederdeppe, ...
PloS one 10 (7), e0130050, 2015
|Food insecurity, neighborhood food access, and food assistance in Philadelphia|
VL Mayer, A Hillier, MA Bachhuber, JA Long
Journal of Urban Health 91 (6), 1087-1097, 2014
|Use of cannabis to relieve pain and promote sleep by customers at an adult use dispensary|
M Bachhuber, JH Arnsten, G Wurm
Journal of psychoactive drugs 51 (5), 400-404, 2019
|Hospitalization rates of people living with HIV in the United States, 2009|
MA Bachhuber, WN Southern
Public health reports 129 (2), 178-186, 2014
|Understanding Americans’ views on opioid pain reliever abuse|
CL Barry, A Kennedy‐Hendricks, SE Gollust, J Niederdeppe, ...
Addiction 111 (1), 85-93, 2016
|Description and outcomes of a buprenorphine maintenance treatment program integrated within Prevention Point Philadelphia, an urban syringe exchange program|
MA Bachhuber, C Thompson, A Prybylowski, J Benitez, S Mazzella, ...
Substance abuse 39 (2), 167-172, 2018
|Prescription monitoring programs and emergency department visits involving opioids, 2004–2011|
BC Maughan, MA Bachhuber, N Mitra, JL Starrels
Drug and alcohol dependence 156, 282-288, 2015
|Cannabis use is associated with lower odds of prescription opioid analgesic use among HIV-infected individuals with chronic pain|
NL Sohler, JL Starrels, L Khalid, MA Bachhuber, JH Arnsten, S Nahvi, ...
Substance use & misuse 53 (10), 1602-1607, 2018
|Prescription monitoring programs and emergency department visits involving benzodiazepine misuse: Early evidence from 11 United States metropolitan areas|
MA Bachhuber, BC Maughan, N Mitra, J Feingold, JL Starrels
International Journal of Drug Policy 28, 120-123, 2016
|Deaths from unintentional injury, homicide, and suicide during or within 1 year of pregnancy in Philadelphia|
PK Mehta, MA Bachhuber, R Hoffman, SK Srinivas
American journal of public health 106 (12), 2208-2210, 2016
|Increase in anti-tuberculosis drug resistance in Botswana: results from the fourth National Drug Resistance Survey|
HJ Menzies, G Moalosi, V Anisimova, V Gammino, C Sentle, ...
The International journal of tuberculosis and lung disease 18 (9), 1026-1033, 2014
|Association of chest radiographic abnormalities with tuberculosis disease in asymptomatic HIV-infected adults|
T Agizew, MA Bachhuber, S Nyirenda, V Makwaruzi, Z Tedla, ...
The International journal of tuberculosis and lung disease 14 (3), 324-331, 2010
|Medication for opioid use disorder: a national survey of primary care physicians|
EE McGinty, EM Stone, A Kennedy-Hendricks, MA Bachhuber, CL Barry
Annals of internal medicine 173 (2), 160-162, 2020
|Changes in testing for human immunodeficiency virus, sexually transmitted infections, and hepatitis C virus in opioid treatment programs|
MA Bachhuber, CO Cunningham
Jama 310 (24), 2671-2672, 2013